Searched for
JB PHARMA RESULTS
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...- CCI clears Torrent Pharma's proposal to buy stake in JB ChemicalsIndia's competition regulator CCI has approved Torrent Pharmaceuticals' acquisition of a stake in JB Chemicals and Pharmaceuticals. This de...
- Torrent expects JB Chemicals acquisition deal to close in 15–18 monthsTorrent Pharmaceuticals is set to acquire a major stake in J B Chemicals. The deal is expected to finalize in 15 to 18 months. This acquisi...
- JB Pharma Q2 Results: Net profit jumps 16% to Rs 175 crore, revenue up 13%JB Pharma reported a 16% YoY increase in Q2FY25 net profit to Rs 175 crore, driven by 22% growth in domestic business. Revenues rose 13% to...
- JB Pharma Q1 Results: Net profit jumps 25% YoY to Rs 177 croreThe drug maker had reported a net profit of Rs 142 crore in the year-ago period.Revenue for the quarter rose 12% YoY to Rs 1004 crore
- Local pharma companies queue up for JB Chemicals & PharmaceuticalsMankind Pharma, Dr Reddy's Laboratories, and Torrent Pharma are interested in acquiring JB Chemicals & Pharmaceuticals from KKR. KKR's inve...
- JB Pharma expects India business to grow above market growth rate in FY25: CEO Nikhil ChopraJB Pharma, led by CEO Nikhil Chopra, forecasts 12-14% revenue growth and aims to increase Ebitda margins by 27-28% in FY25. The growth is d...
- JB Pharma Q4 Results: Net profit jumps 43% YoY to Rs 126 croreThe Mumbai-based company reported operating earnings before interest, taxes, depreciation and amortisation (EBITDA) at Rs 210 crore, up fro...
- Hot Stocks: Brokerages view on Trent, Nazara Technologies, Nestle and JB PharmaCitigroup maintained a buy rating on Nestle India post Q3 results with a target price of Rs 2900. The company reported steady revenue growt...
- JB Pharma Q3 Results: Net profit jumps 26% to Rs 134 croreThe drug maker had reported a net profit of Rs 106 crore in the year-ago period. Revenue for the quarter rose 7% YoY to Rs 845 crore The Mu...
- Hot Stocks: Brokerage view on Prestige Estates, JB Pharma, Uno Minda and Jyothy LabsCitigroup maintained a buy rating on Prestige Estates but raised the target price to Rs 982 from Rs 693 earlier.
- JB Pharma Q2 Results: Net profit jumps 35% YoY to Rs 151 croreRevenue for the quarter rose 9% YoY to Rs 882 crore. The Mumbai-based company reported operating earnings before interest, taxes, depreciat...
- JB Pharma Q1 Results: Net profit surges 35% YoY to Rs 142 croreDomestic business revenue grew 17% YoY to Rs 489 crores in Q1FY24, despite sales for the acute business being impacted due to the delayed m...
- JB Pharma Q3 Results: Net profit rises 26% to Rs 106 croreThe earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 28% YoY to Rs 193 crore. The EBTIDA margin dropped 120 basi...
- JB Pharma profit rises 13% to Rs 111 crore in Q2FY23Revenues rose 36% YoY to Rs 809 crore in Q2FY23, compared to Rs 593 crore in Q2FY22.Earnings before interest, depreciation and taxes (EBITD...
- JB Pharma net profit down 12% to Rs 105 croreThe company reported net profit of Rs 119 crore during corresponding period of the previous year.The company attributed the drop in net pro...
- JB Chemicals & Pharma Q2 results: Net profit up 32% to Rs 98 crConsolidated revenue from operations of the company stood at Rs 593.01 crore for the quarter under consideration. It was Rs 443.56 crore fo...
- Apax, KKR and PAG in final lap for JB Chemicals buyoutJB Chemicals has a market cap of Rs 5,568 crore. During the last three months, shares of JB Chemicals have gone up 26% on BSE. On Wednesday...
- High pressure on pharma margins; buy JB Chemicals: SharekhanLupin and Glenmark as clear winners with a likely upside from Para IV/niche opportunities, strong domestic franchise, low vulnerability to ...
- Domestic pharma companies may see a phase of consolidation: Ajay Parmar, Emkay Global Financial ServicesCompanies having more income from the domestic business can see margins declining.
Load More
